Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-0.97x0.59x1.16x - -0.25x-0.25x - 194M
32.3x6.14x0.76x8.39x25.37x26.1x0.06% 54.82B
16.24x3.1x-1.69x4.87x10.58x12.29x1.85% 43.27B
-16.97x1.05x2.61x3.74x-6.55x-5.31x-.--% 21.79B
-34.28x46.68x0.59x11.45x-33.43x-36.15x-.--% 19.92B
19.37x1.9x1.36x3.76x9.77x11.75x-.--% 15.67B
21.29x2.42x-0.96x4.28x14.15x15.77x-.--% 15.26B
16.63x4.71x1.21x4.79x11.24x12.31x-.--% 13.22B
38.34x9.51x0.43x14.76x43.34x38.61x0.17% 11.58B
-419.07x17.2x8.5x28.52x-3179.37x-312.13x-.--% 11.94B
-11.51x135.3x0.56x2979.32x-13.91x-11.33x-.--% 10.13B
-69x24.17x1.47x6.91x-65.16x-50.75x-.--% 10.87B
1073.47x7.41x-10.15x12.5x70.92x172.66x-.--% 10.34B
-22.4x23x-0x20.23x-25.96x-21x-.--% 9.96B
-21.37x8.25x16.08x820.4x-18.69x-18.6x-.--% 9.74B
-10.38x-42.99x8.94x78x-11.64x-11.33x-.--% 9.11B
-8.21x - -0.07x - - - - 7.31B
10.34x4.95x0.03x6.61x10.7x11.3x-.--% 7.28B
113.84x2.3x-2x4.57x22.7x49.54x0.13% 7.04B
25.26x4.13x-2.02x5.7x22.17x25.29x - 6.86B
Average 37.65x 13.67x 1.34x 223.27x -163.90x -4.80x 0.13% 14.81B
Weighted average by Cap. 28.36x 12.37x 0.99x 142.27x -125.22x -1.17x 0.31%
Bio Therapeutic Drugs
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!